Artemis Medicare Services Limited

NSEI:ARTEMISMED Stock Report

Market Cap: ₹31.5b

Artemis Medicare Services Management

Management criteria checks 2/4

Artemis Medicare Services' CEO is Devlina Chakravarty, appointed in Jan 2014, has a tenure of 10.5 years. total yearly compensation is ₹183.34M, comprised of 35.3% salary and 64.7% bonuses, including company stock and options. directly owns 2.15% of the company’s shares, worth ₹678.64M. The average tenure of the management team and the board of directors is 4.1 years and 10.9 years respectively.

Key information

Devlina Chakravarty

Chief executive officer

₹183.3m

Total compensation

CEO salary percentage35.3%
CEO tenure10.5yrs
CEO ownership2.2%
Management average tenure4.1yrs
Board average tenure10.9yrs

Recent management updates

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Artemis Medicare Services Limited's (NSE:ARTEMISMED) CEO For Now

Jul 18
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Artemis Medicare Services Limited's (NSE:ARTEMISMED) CEO For Now

Recent updates

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Artemis Medicare Services Limited's (NSE:ARTEMISMED) CEO For Now

Jul 18
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Artemis Medicare Services Limited's (NSE:ARTEMISMED) CEO For Now

Artemis Medicare Services Limited's (NSE:ARTEMISMED) P/E Is Still On The Mark Following 31% Share Price Bounce

Jul 16
Artemis Medicare Services Limited's (NSE:ARTEMISMED) P/E Is Still On The Mark Following 31% Share Price Bounce

After Leaping 27% Artemis Medicare Services Limited (NSE:ARTEMISMED) Shares Are Not Flying Under The Radar

Apr 13
After Leaping 27% Artemis Medicare Services Limited (NSE:ARTEMISMED) Shares Are Not Flying Under The Radar

Artemis Medicare Services (NSE:ARTEMISMED) Has A Pretty Healthy Balance Sheet

Jun 14
Artemis Medicare Services (NSE:ARTEMISMED) Has A Pretty Healthy Balance Sheet

Artemis Medicare Services (NSE:ARTEMISMED) Has A Somewhat Strained Balance Sheet

Mar 15
Artemis Medicare Services (NSE:ARTEMISMED) Has A Somewhat Strained Balance Sheet

Capital Allocation Trends At Artemis Medicare Services (NSE:ARTEMISMED) Aren't Ideal

Aug 31
Capital Allocation Trends At Artemis Medicare Services (NSE:ARTEMISMED) Aren't Ideal

Is Artemis Medicare Services (NSE:ARTEMISMED) A Risky Investment?

Jul 30
Is Artemis Medicare Services (NSE:ARTEMISMED) A Risky Investment?

Artemis Medicare Services (NSE:ARTEMISMED) Is Reinvesting At Lower Rates Of Return

May 13
Artemis Medicare Services (NSE:ARTEMISMED) Is Reinvesting At Lower Rates Of Return

Returns On Capital At Artemis Medicare Services (NSE:ARTEMISMED) Paint A Concerning Picture

Jan 11
Returns On Capital At Artemis Medicare Services (NSE:ARTEMISMED) Paint A Concerning Picture

Artemis Medicare Services (NSE:ARTEMISMED) Has A Pretty Healthy Balance Sheet

Dec 10
Artemis Medicare Services (NSE:ARTEMISMED) Has A Pretty Healthy Balance Sheet

There Are Reasons To Feel Uneasy About Artemis Medicare Services' (NSE:ARTEMISMED) Returns On Capital

Sep 11
There Are Reasons To Feel Uneasy About Artemis Medicare Services' (NSE:ARTEMISMED) Returns On Capital

Artemis Medicare Services (NSE:ARTEMISMED) Has A Somewhat Strained Balance Sheet

Jul 01
Artemis Medicare Services (NSE:ARTEMISMED) Has A Somewhat Strained Balance Sheet

There Are Reasons To Feel Uneasy About Artemis Medicare Services' (NSE:ARTEMISMED) Returns On Capital

May 11
There Are Reasons To Feel Uneasy About Artemis Medicare Services' (NSE:ARTEMISMED) Returns On Capital

We Think Artemis Medicare Services (NSE:ARTEMISMED) Is Taking Some Risk With Its Debt

Mar 16
We Think Artemis Medicare Services (NSE:ARTEMISMED) Is Taking Some Risk With Its Debt

Is Artemis Medicare Services (NSE:ARTEMISMED) Likely To Turn Things Around?

Jan 22
Is Artemis Medicare Services (NSE:ARTEMISMED) Likely To Turn Things Around?

Is Artemis Medicare Services (NSE:ARTEMISMED) A Risky Investment?

Nov 13
Is Artemis Medicare Services (NSE:ARTEMISMED) A Risky Investment?

Market Still Lacking Some Conviction On Artemis Medicare Services Limited (NSE:ARTEMISMED)

Jul 20
Market Still Lacking Some Conviction On Artemis Medicare Services Limited (NSE:ARTEMISMED)

CEO Compensation Analysis

How has Devlina Chakravarty's remuneration changed compared to Artemis Medicare Services's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024₹183m₹65m

₹491m

Dec 31 2023n/an/a

₹456m

Sep 30 2023n/an/a

₹445m

Jun 30 2023n/an/a

₹400m

Mar 31 2023₹139m₹46m

₹386m

Dec 31 2022n/an/a

₹412m

Sep 30 2022n/an/a

₹373m

Jun 30 2022n/an/a

₹363m

Mar 31 2022₹49m₹46m

₹318m

Dec 31 2021n/an/a

₹313m

Sep 30 2021n/an/a

₹301m

Jun 30 2021n/an/a

₹221m

Mar 31 2021₹51m₹48m

₹65m

Dec 31 2020n/an/a

-₹19m

Sep 30 2020n/an/a

-₹16m

Jun 30 2020n/an/a

₹38m

Mar 31 2020₹52m₹48m

₹198m

Compensation vs Market: Devlina's total compensation ($USD2.19M) is above average for companies of similar size in the Indian market ($USD243.47K).

Compensation vs Earnings: Devlina's compensation has increased by more than 20% in the past year.


CEO

Devlina Chakravarty (56 yo)

10.5yrs

Tenure

₹183,337,000

Compensation

Dr. Devlina Chakravarty, M.D., DNB, DMRD, Radiolog,y serves as Chief Executive Officer at Artemis Medicare Services Limited and its Managing Director and Executive Director since February 2, 2015. Dr. Chak...


Leadership Team

NamePositionTenureCompensationOwnership
Devlina Chakravarty
CEO, MD & Executive Director10.5yrs₹183.34m2.15%
₹ 678.6m
Sanjiv Kothari
Chief Financial Officerno data₹8.63mno data
Poonam Makkar
Company Secretary & Compliance Officer1.7yrs₹4.24mno data
Ashutosh Kumar Jha
Chief-Strategyno datano datano data
Vivek Singh
Head of Legalno datano datano data
Saras Malik
Chief People Officer of Human Resources & Trainingno datano datano data
Manju Aggarwal
Chief Medical Services & Chairperson of Nephrology4.1yrsno datano data
Kapil Kumar
Chief Technology Officer- Medical Informaticsno datano datano data

4.1yrs

Average Tenure

Experienced Management: ARTEMISMED's management team is considered experienced (4.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Devlina Chakravarty
CEO, MD & Executive Director9.3yrs₹183.34m2.15%
₹ 678.6m
Onkar Kanwar
Non-Executive Non-Independent Chairman17.8yrs₹400.00k0.0037%
₹ 1.2m
Neeraj Kanwar
Non-Executive & Non-Independent Director16.5yrs₹480.00kno data
Nirmal Ganguly
Non-Executive & Non-Independent Director10.4yrs₹2.92mno data
Sanjaya Baru
Non-Executive Independent Director11.4yrs₹480.00kno data
Deepa Wadhwa
Non-Executive Independent Woman Director4.2yrs₹540.00kno data
Sunil Tandon
Non-Executive Independent Director3.2yrs₹520.00kno data
Sanjib Sen
Independent Director3.9yrs₹460.00kno data
Shalini Chand
Non-Executive & Non-Independent Director17.5yrs₹480.00kno data
Subbaraman Narayan
Non-Executive Independent Director17.8yrs₹560.00kno data

10.9yrs

Average Tenure

63yo

Average Age

Experienced Board: ARTEMISMED's board of directors are seasoned and experienced ( 10.9 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.